Analyst Ratings for Redhill Biopharma (RDHL)

RDHL Rating Summary

  |   Expand Research on RDHL
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/31/2021 Cantor Fitzgerald
» Updated 11/22/2022		 Brandon Folkes New Coverage Overweight
(N/A)		 1.00
(11.00)		 8.59
(1.00)		 -88.36% Details
5/28/2021 WBB Securities Steve Brozak Downgrade Buy
(Strong Buy)		 N/A
(N/A)		 7.14
(1.00)		 -85.99% Details